Menu Search
Equities

Modern Chinese Medicine Group Co Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
1643:HKG.HS

Modern Chinese Medicine Group Co Ltd

Actions
  • Price (HKD)0.77
  • Today's Change-0.03 / -3.75%
  • Shares traded1.70m
  • 1 Year change+97.44%
  • Beta0.6234
Data delayed at least 15 minutes, as of Feb 06 2026 08:08 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Modern Chinese Medicine Group Co Ltd is an investment holding company primarily engaged in the production of proprietary Chinese medicine. The Company is mainly engaged in the provision of over-the-counter and prescribed medicines intended for use by the middle-aged and the elderly. The Company’s main products include Vigour and Vitality Supplement Pill, Circulation Enhancement Pill, Cardiotonic Enhancement Capsule, Kidney Invigoration Pill, Heart Wellness Capsule, Menstrual Discomfort Relief Pill, Liver Detox Tablet, Additional Ingredient Huoxiang Zheng Qi Pill, Liver-dispersing and Stomach Regulating Pill, and Fever- removing and Detoxification Pill. The intended therapeutic effects of the Company’s major products are for the treatment and alleviation of deficiency and blood-stasis condition, cardio-cerebrovascular condition, digestive and gastrointestinal condition, and gynaecological condition. The Company mainly conducts its businesses within domestic market.

  • Revenue in HKD (TTM)227.57m
  • Net income in HKD21.36m
  • Incorporated2019
  • Employees190.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.